171 related articles for article (PubMed ID: 31204875)
1. Angioimmunoblastic T-cell lymphoma and myelodysplastic syndrome with mutations in
Tobiasson M; Pandzic T; Cavelier L; Sander B; Wahlin BE
Leuk Lymphoma; 2019 Dec; 60(13):3316-3319. PubMed ID: 31204875
[No Abstract] [Full Text] [Related]
2. Single-agent lenalidomide is effective in the treatment of a heavily pretreated and refractory angioimmunoblastic T-cell lymphoma patient.
Broccoli A; Pellegrini C; Celli M; Argnani L; Agostinelli C; Pileri S; Zinzani PL
Clin Lymphoma Myeloma Leuk; 2014 Aug; 14(4):e119-22. PubMed ID: 24629851
[No Abstract] [Full Text] [Related]
3. A four-year spontaneous remission of angioimmunoblastic T-cell lymphoma.
Cornish N; Maybury B; Otton S
Br J Haematol; 2018 Jan; 180(2):176. PubMed ID: 29048103
[No Abstract] [Full Text] [Related]
4. Multifaceted modes of action of azacytidine: a riddle wrapped up in an enigma.
Lamprianidou E; Zoulia E; Bernard E; Kordella C; Papoutselis M; Bezirgiannidou Z; Vrachiolias G; Papaemmanuil E; Kotsianidis I
Leuk Lymphoma; 2019 Dec; 60(13):3277-3281. PubMed ID: 31185765
[No Abstract] [Full Text] [Related]
5. Using PU.1 and Jun dimerization protein 2 transcription factor expression in myelodysplastic syndromes to predict treatment response and leukaemia transformation.
Boasman K; Simmonds MJ; Graham C; Saunthararajah Y; Rinaldi CR
Ann Hematol; 2019 Jun; 98(6):1529-1531. PubMed ID: 30721335
[No Abstract] [Full Text] [Related]
6. Bone Marrow Involvement of Epstein-Barr Virus-Positive Large B-Cell Lymphoma in a Patient with Angioimmunoblastic T-Cell Lymphoma.
Lee T; Park BG; You E; Cho YU; Jang S; Lee SM; Suh C; Park CJ
Ann Lab Med; 2018 Mar; 38(2):172-175. PubMed ID: 29214764
[No Abstract] [Full Text] [Related]
7. Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-azacytidine.
Voso MT; Fabiani E; Piciocchi A; Matteucci C; Brandimarte L; Finelli C; Pogliani E; Angelucci E; Fioritoni G; Musto P; Greco M; Criscuolo M; Fianchi L; Vignetti M; Santini V; Hohaus S; Mecucci C; Leone G
Leukemia; 2011 Dec; 25(12):1910-3. PubMed ID: 21760590
[No Abstract] [Full Text] [Related]
8. Efficacy of 5-azacytidine in a TET2 mutated angioimmunoblastic T cell lymphoma.
Cheminant M; Bruneau J; Kosmider O; Lefrere F; Delarue R; Gaulard P; Radford I; Derrieux C; Hermine O; Lemonnier F
Br J Haematol; 2015 Mar; 168(6):913-6. PubMed ID: 25312805
[No Abstract] [Full Text] [Related]
9. Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias.
Itzykson R; Kosmider O; Cluzeau T; Mansat-De Mas V; Dreyfus F; Beyne-Rauzy O; Quesnel B; Vey N; Gelsi-Boyer V; Raynaud S; Preudhomme C; Adès L; Fenaux P; Fontenay M;
Leukemia; 2011 Jul; 25(7):1147-52. PubMed ID: 21494260
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of angioimmunoblastic lymphadenopathy with dysproteinemia with fludarabine.
Ong ST; Koeppen H; Larson RA; Olopade OI
Blood; 1996 Sep; 88(6):2354-5. PubMed ID: 8822958
[No Abstract] [Full Text] [Related]
11. Epigenetic therapies move into new territory, but how exactly do they work?
Tuma RS
J Natl Cancer Inst; 2009 Oct; 101(19):1300-1. PubMed ID: 19755677
[No Abstract] [Full Text] [Related]
12. Myelodysplastic syndrome associated with immunoblastic lymphadenopathy-like T-cell lymphoma: simultaneous clinical improvement with chemotherapy.
Anzai T; Hirose W; Nakane H; Kawagoe M; Kawai T; Watanabe K
Jpn J Clin Oncol; 1994 Apr; 24(2):106-10. PubMed ID: 8158857
[TBL] [Abstract][Full Text] [Related]
13. Neuropathy associated with angioimmunoblastic lymphadenopathy-like T-cell lymphoma.
Sonobe M; Yasuda H; Okabe H; Terada M; Maeda K; Kawabata T; Kikkawa R
Intern Med; 1998 Jul; 37(7):631-4. PubMed ID: 9711895
[TBL] [Abstract][Full Text] [Related]
14. [Immunoblastic lymphadenopathy-like T cell lymphoma with high level of serum interleukin-2 and various allergic reactions].
Tsujisaki M; Nakahara S; Kazama Y; Shimizu H; Yoshimoto M; Takahashi T; Okada Y; Sasaki S; Imai K
Nihon Rinsho Meneki Gakkai Kaishi; 2002 Dec; 25(6):452-7. PubMed ID: 12630426
[No Abstract] [Full Text] [Related]
15. A male with angioimmunoblastic T-cell lymphoma and proliferative glomerulonephritis.
De Samblanx H; Verhoef G; Zachée P; Vandenberghe P
Ann Hematol; 2004 Jul; 83(7):455-9. PubMed ID: 15034757
[TBL] [Abstract][Full Text] [Related]
16. RNA cytosine methylation and methyltransferases mediate chromatin organization and 5-azacytidine response and resistance in leukaemia.
Cheng JX; Chen L; Li Y; Cloe A; Yue M; Wei J; Watanabe KA; Shammo JM; Anastasi J; Shen QJ; Larson RA; He C; Le Beau MM; Vardiman JW
Nat Commun; 2018 Mar; 9(1):1163. PubMed ID: 29563491
[TBL] [Abstract][Full Text] [Related]
17. TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients.
Bejar R; Lord A; Stevenson K; Bar-Natan M; Pérez-Ladaga A; Zaneveld J; Wang H; Caughey B; Stojanov P; Getz G; Garcia-Manero G; Kantarjian H; Chen R; Stone RM; Neuberg D; Steensma DP; Ebert BL
Blood; 2014 Oct; 124(17):2705-12. PubMed ID: 25224413
[TBL] [Abstract][Full Text] [Related]
18. Positive HIV ELISA test, autoimmune hemolytic anemia, and generalized lymphadenopathy: a unifying diagnosis.
Castillo JJ; Sinclair N; Stachurski D; Jacobsen ED
Am J Hematol; 2011 Aug; 86(8):690-3. PubMed ID: 21630306
[No Abstract] [Full Text] [Related]
19. Partial restoration of CD20 protein expression and rituximab sensitivity after treatment with azacitidine in CD20-negative transformed diffuse large B cell lymphoma after using rituximab.
Hiraga J; Tomita A; Suzuki N; Takagi Y; Narita M; Kagami Y
Ann Hematol; 2018 Nov; 97(11):2253-2255. PubMed ID: 29725760
[No Abstract] [Full Text] [Related]
20. TET2 mutations in B cells of patients affected by angioimmunoblastic T-cell lymphoma.
Schwartz FH; Cai Q; Fellmann E; Hartmann S; Mäyränpää MI; Karjalainen-Lindsberg ML; Sundström C; Scholtysik R; Hansmann ML; Küppers R
J Pathol; 2017 Jun; 242(2):129-133. PubMed ID: 28337768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
